Manufacturing licence suspension for substandard drugs: Government proposes stricter action under Drugs Rules, 1945

The Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, requiring immediate suspension of manufacturing licences when a Government Analyst reports that a drug is not of standard quality. Once a drug is reported as substandard, its manufacturing licence would be suspended. The manufacturer would have to identify the cause of the quality failure and implement corrective and preventive actions. The licence would remain suspended until the licensing authority is satisfied with these measures and verifies their implementation. The draft rules were notified on 28 October 2026, inviting public comments within 30 days of publication.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.